MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 七月 23, 2026MOH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
MOH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2011年5月23日 | 3-for-2 | 正向 |
关于 Molina Healthcare Inc Common Stock 公司概况（来自维基百科）
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | MOH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.05年均值 ≈21.1 | ≈21.1 | 36.3 | 估值过高 | |
| P/S (TTM) | 0.25年均值 ≈0.5 | ≈0.5 | 0.7 | 低估 | |
| 市净率 (MRQ) | 2.45年均值 ≈4.3 | ≈4.3 | 3.9 | 低估 | |
| 企业价值 / EBITDA (TTM) | 12.75年均值 ≈7.0 | ≈7.0 | 16.1 | 低估 | |
| 股价/自由现金流 (TTM) | 36.45年均值 ≈14.4 | ≈14.4 | · | · | |
| 市现率 (TTM) | 27.05年均值 ≈11.5 | ≈11.5 | · | · | |
| 市值/营收 (TTM) | 0.15年均值 ≈0.3 | ≈0.3 | · | · | |
| 市值/自由现金流 (TTM) | 17.45年均值 ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 5.35年均值 ≈7.7 | ≈7.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | MOH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 0.46%5年均值 ≈3.6% | ≈3.6% | 3.5% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | 0.83%5年均值 ≈4.1% | ≈4.1% | 3.7% | 弱 | |
| 税前利润率 (TTM) | -0.01%5年均值 ≈3.2% | ≈3.2% | 2.8% | 弱 | |
| 净利润率 (TTM) | -0.02%5年均值 ≈2.4% | ≈2.4% | 2.9% | 弱 | |
| ROA (TTM) | -0.04%5年均值 ≈6.3% | ≈6.3% | 3.0% | 持平 | |
| ROE (TTM) | -0.16%5年均值 ≈23.1% | ≈23.1% | 10.1% | 持平 | |
| ROIC | 8.0%5年均值 ≈15.3% | ≈15.3% | 8.0% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | MOH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.95年均值 ≈0.7 | ≈0.7 | 0.7 | 高负债 | |
| 流动比率 (MRQ) | 1.75年均值 ≈1.5 | ≈1.5 | 1.7 | 持平 | |
| 速动比率 (MRQ) | 1.65年均值 ≈1.5 | ≈1.5 | 1.3 | 流动性强 | |
| 长期负债/股东权益 (MRQ) | 0.95年均值 ≈0.7 | ≈0.7 | 0.7 | 高负债 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | MOH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 11.8%5年均值 ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 12.4%5年均值 ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 18.5% | · | · | · | |
| EPS YoY | -56.3%5年均值 ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (净利润同比增长) | -60.0%5年均值 ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | -13.0%5年均值 ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | -15.8%5年均值 ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | -6.9% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | MOH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 2.95年均值 ≈2.6 | ≈2.6 | 2.4 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 13.35年均值 ≈13.5 | ≈13.5 | 16.3 | 低于平均水平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$2.4M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 21, 2026 | $1.51 | $1.40 | 7.5% |
| 2026年3月31日 | $2.35 | $1.94 | 21.0% | |
| 2025年12月31日 | $-2.75 | $0.34 | -916.0% | |
| 2025年9月30日 | $1.84 | $3.94 | -53.3% | |
| 2025年6月30日 | $5.48 | $5.85 | -6.3% | |
| 2025年3月31日 | $6.08 | $6.02 | 1.1% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| 营业利润率 % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| 净收入 | $472M | $1.18B | $1.09B | $792M | $659M |
| 稀释后每股收益 (EPS) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| 流动比率 | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| 速动比率 | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-636M | $544M | $1.58B | $682M | $2.04B |
机构持有人 (13F) 673 家申报者 · $13.8B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 159 (+18 与上一季度对比) | 68 (-75 与上一季度对比) | 219 (+23 与上一季度对比) | 181 (+8 与上一季度对比) | +1.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $1503052088 | 6572156 | 10.91% | 股份 |
| VANGUARD GROUP INC | $1055736837 | 6083536 | 7.66% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $806903452 | 3560601 | 5.86% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638128574 | 2790243 | 4.63% | 股份 |
| Capital World Investors | $586138203 | 2562913 | 4.26% | 股份 |
| Lingotto Investment Management LLP | $574377763 | 2511490 | 4.17% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $538648191 | 2355261 | 3.91% | 股份 |
| FMR LLC | $427964063 | 1871290 | 3.11% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $427014918 | 1867140 | 3.10% | 股份 |
| STATE STREET CORP | $401475303 | 1755467 | 2.91% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $318659985 | 1393338 | 2.31% | 股份 |
| GOLDMAN SACHS GROUP INC | $298810862 | 1306563 | 2.17% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $289810242 | 1267207 | 2.10% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $289611501 | 1266338 | 2.10% | 股份 |
| Capital Research Global Investors | $249797804 | 1092251 | 1.81% | 股份 |
| MORGAN STANLEY | $230316927 | 1007068 | 1.67% | 股份 |
| HARRIS ASSOCIATES L P | $218980250 | 957500 | 1.59% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $204005369 | 891772 | 1.48% | 股份 |
| 8 KNOTS MANAGEMENT, LLC | $198942438 | 1146378 | 1.44% | 股份 |
| MANNING & NAPIER ADVISORS LLC | $152338582 | 663669 | 1.11% | 股份 |
| UBS Group AG | $142749967 | 624180 | 1.04% | 股份 |
| Long Focus Capital Management, LLC | $139507000 | 610000 | 1.01% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131512792 | 575045 | 0.95% | 股份 |
| TWO SIGMA ADVISERS, LP | $116582437 | 671790 | 0.85% | 股份 |
| Invesco Ltd. | $116332600 | 508669 | 0.84% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115548617 | 505241 | 0.84% | 股份 |
| NORTHERN TRUST CORP | $88292838 | 386064 | 0.64% | 股份 |
| NORGES BANK | $87054426 | 380649 | 0.63% | 股份 |
| Bank of New York Mellon Corp | $86138019 | 376642 | 0.63% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82789400 | 362000 | 0.60% | 卖出期权 |
| BNP PARIBAS FINANCIAL MARKETS | $82559556 | 360995 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $75497758 | 330117 | 0.55% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $72051935 | 315050 | 0.52% | 股份 |
| BANK OF AMERICA CORP /DE/ | $71479956 | 312549 | 0.52% | 股份 |
| Amundi | $59944786 | 262111 | 0.44% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $57795692 | 252714 | 0.42% | 股份 |
| Maple Rock Capital Partners Inc. | $55642710 | 243300 | 0.40% | 股份 |
| Russell Investments Group, Ltd. | $53133740 | 232165 | 0.39% | 股份 |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52660005 | 230258 | 0.38% | 股份 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51238863 | 224044 | 0.37% | 股份 |
| D. E. Shaw & Co., Inc. | $47575775 | 208027 | 0.35% | 股份 |
| CITIGROUP INC | $47390070 | 207215 | 0.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46357490 | 202700 | 0.34% | 买入期权 |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45740000 | 200000 | 0.33% | 股份 |
| DEUTSCHE BANK AG\ | $45272766 | 197957 | 0.33% | 股份 |
| INVESTMENT HOUSE LLC | $44310854 | 193751 | 0.32% | 股份 |
| JANE STREET GROUP, LLC | $43224300 | 189000 | 0.31% | 卖出期权 |
| Fiera Capital Corp | $43130075 | 188588 | 0.31% | 股份 |
| Summit Street Capital Management, LLC | $41630489 | 182031 | 0.30% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41211511 | 180199 | 0.30% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 申报 | 2018年1月23日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 62 位内幕人士 · 25 位高管 · 19 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 2007年8月22日 S | 5734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 2005年7月1日 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 2026年3月1日 A | 83251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 2018年6月6日 D | 48390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 2026年6月30日 A | 90178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2018年2月2日 D | 28730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 2026年7月1日 F | 21636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 2026年6月30日 A | 67313 | 0 | 1 | $-3314983 |
| Marc Russo | EVP, Health Plans | 2023年8月7日 S | 37093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 2020年3月1日 F | 8846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 2018年3月1日 F | 25084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 2017年6月30日 A | 29441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 2010年8月16日 S | 16782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 2010年7月1日 F | 51006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 2008年12月5日 J | 50000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 2008年8月7日 F | 16199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 2008年6月30日 A | 15304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 2007年6月29日 A | 7822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 2007年3月1日 A | 5150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 2007年3月1日 A | 8500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 2007年3月1日 A | 8713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 2007年2月28日 S | 4774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 2007年2月16日 F | 5000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 2005年12月30日 J | 12564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 2004年8月16日 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | 董事 | 2026年10月1日 A | 4688 | 0 | 0 | $0 |
| Richard M Schapiro | 董事 | 2026年10月1日 A | 12615 | 0 | 1 | $-51058 |
| Richard C Zoretic | 董事 | 2026年10月1日 A | 9693 | 1 | 0 | $100128 |
| Leo P Grohowski | 董事 | 2026年10月1日 A | 1846 | 0 | 0 | $0 |
| Francis S Soistman JR | 董事 | 2026年10月1日 A | 1211 | 0 | 0 | $0 |
| Dale B Wolf | 董事 | 2026年10月1日 A | 15937 | 0 | 0 | $0 |
| Steven J Orlando | 董事 | 2026年10月1日 A | 18271 | 0 | 0 | $0 |
| Ronna Romney | 董事 | 2026年10月1日 A | 18173 | 0 | 1 | $-74342 |
| Barbara L Brasier | 董事 | 2026年10月1日 A | 6122 | 0 | 0 | $0 |
| Daniel Cooperman | 董事 | 2025年4月1日 A | 6383 | 0 | 0 | $0 |
| Garrey Carruthers | 董事 | 2021年4月1日 A | 5265 | 0 | 0 | $0 |
| Charles Z Fedak | 董事 | 2019年4月1日 A | 19092 | 0 | 0 | $0 |
| John C Molina | 董事 | 2018年2月20日 S | 372930 | 0 | 0 | $0 |
| Frank E Murray MD | 董事 | 2017年10月1日 A | 16811 | 0 | 0 | $0 |
| Steven James | 董事 | 2016年4月1日 A | 15024 | 0 | 0 | $0 |
| John P Szabo JR | 董事 | 2015年4月1日 A | 17097 | 0 | 0 | $0 |
| Sally K Richardson | 董事 | 2012年5月3日 A | 47537 | 0 | 0 | $0 |
| Wayne B Lowell | 董事 | 2007年5月10日 A | 10011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | 董事 | 2004年2月10日 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | 10% 所有者 | 2009年12月14日 J | 2137134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | 10% 所有者 | 2006年6月22日 S | 2926907 | 0 | 0 | $0 |
| Maurice Hebert | · | 2026年5月14日 S | 12815 | 0 | 1 | $-114930 |
| Joseph M Zubretsky | · | 2026年3月1日 A | 99015 | 0 | 0 | $0 |
| Thomas L Tran | · | 2021年5月24日 F | 29775 | 0 | 0 | $0 |
| Norman Nichols | · | 2018年8月8日 S | 47415 | 0 | 0 | $0 |
| Harold Gooch | · | 2018年6月30日 A | 7063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 2017年12月11日 S | 61125 | 0 | 0 | $0 |
| James W Howatt | · | 2010年3月19日 S | 34081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 2009年11月5日 G | 1200 | 0 | 0 | $0 |
| Josephine M Molina | · | 2008年8月6日 J | 345701 | 0 | 0 | $0 |
| Janet M Watt | · | 2008年8月6日 J | 284641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 2008年8月6日 J | 345701 | 0 | 0 | $0 |
| Zarina Sparling | · | 2008年2月21日 M | 9380 | 0 | 0 | $0 |
| Mary R Molina | · | 2006年9月27日 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 2006年5月11日 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 2005年6月30日 J | 1908 | 0 | 0 | $0 |
| David W Erickson | · | 2004年12月2日 M | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 74 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4.23% | 18894 NS | 2026年7月31日 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trus... | 1.71% | 120017 SH | 2026年10月2日 | 每日 |
| RFV · Invesco Exchange-Traded Fund Trust | 1.66% | 29907 SH | 2026年10月2日 | 每日 |
| IHF · iShares Trust | 1.53% | 100080 SH | 2026年9月11日 | 每日 |
| VIOV · VANGUARD ADMIRAL FUNDS | 1.28% | 110553 SH | 2026年8月19日 | 每日 |
| PIZ · Invesco Exchange-Traded Fund Trus... | 1.17% | 105488 SH | 2026年10月2日 | 每日 |
| BSJS · Invesco Exchange-Traded Self-Inde... | 0.76% | 5983000 | 2026年10月2日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.64% | 182154 SH | 2026年8月19日 | 每日 |
| FFLV · FIDELITY COVINGTON TRUST | 0.41% | 343 NS | 2026年7月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.40% | 6790 NS | 2026年7月31日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.31% | 7103 SH | 2026年10月2日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.27% | 198247 NS | 2026年7月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.26% | 8610 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.25% | 758589 SH | 2026年8月19日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.22% | 22626 NS | 2026年7月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.22% | 765 NS | 2026年7月31日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.20% | 3918 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.18% | 156577 SH | 2026年8月19日 | 每日 |
| ESML · iShares Trust | 0.17% | 23899 SH | 2026年9月11日 | 每日 |
| IYH · iShares Trust | 0.17% | 30059 SH | 2026年9月11日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.16% | 67624 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.16% | 7446 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.15% | 24870 NS | 2026年7月31日 | N-PORT |
| SMMD · iShares Trust | 0.14% | 27458 SH | 2026年9月11日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.14% | 1195007 SH | 2026年8月19日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.13% | 597850 SH | 2026年8月19日 | 每日 |
| IWS · iShares Trust | 0.10% | 77233 SH | 2026年9月11日 | 每日 |
| WSML · iShares Trust | 0.10% | 3305 SH | 2026年9月11日 | 每日 |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.09% | 4929 SH | 2026年10月2日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.09% | 68863 NS | 2026年7月31日 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.09% | 3775 SH | 2026年10月2日 | 每日 |
| IWR · iShares Trust | 0.08% | 210604 SH | 2026年9月11日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 35013 SH | 2026年10月2日 | 每日 |
| EMGF · iShares, Inc. | 0.06% | 15805 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.05% | 1409 NS | 2026年7月31日 | N-PORT |
| EMXC · iShares, Inc. | 0.05% | 162911 SH | 2026年9月11日 | 每日 |
| DFSU · Dimensional ETF Trust | 0.04% | 5157 NS | 2026年7月31日 | N-PORT |
| VEGN · ETF Series Solutions | 0.03% | 305 NS | 2026年7月31日 | N-PORT |
| IUSV · iShares Trust | 0.03% | 45470 SH | 2026年9月11日 | 每日 |
| IEMG · iShares, Inc. | 0.03% | 689771 SH | 2026年9月11日 | 每日 |
| EEM · iShares, Inc. | 0.03% | 131827 SH | 2026年9月11日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 31058 SH | 2026年8月19日 | 每日 |
| IWD · iShares Trust | 0.03% | 114206 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.03% | 20443 NS | 2026年7月31日 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.03% | 52472 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.02% | 2686 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 1655258 SH | 2026年8月19日 | 每日 |
| VWO · VANGUARD INTERNATIONAL EQUITY IND... | 0.02% | 868836 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 8548 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 4354 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 11634 SH | 2026年8月19日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.02% | 45023 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.02% | 2946 NS | 2026年7月31日 | N-PORT |
| IXUS · iShares Trust | 0.02% | 126782 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.01% | 14718 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.01% | 35396 SH | 2026年9月11日 | 每日 |
| IYY · iShares Trust | 0.01% | 2168 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.01% | 15184 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.01% | 67059 SH | 2026年9月11日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.01% | 8285 NS | 2026年7月31日 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0.01% | 531000 SH | 2026年9月11日 | 每日 |
| VOXP · Advisors Series Trust | 0.01% | 3 NS | 2026年7月31日 | N-PORT |
| ACWX · iShares Trust | 0.01% | 16724 SH | 2026年9月11日 | 每日 |
| VXUS · VANGUARD STAR FUNDS | 0.01% | 910737 SH | 2026年8月19日 | 每日 |
| VEU · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 145760 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 89282 SH | 2026年8月19日 | 每日 |
| VYMI · VANGUARD WHITEHALL FUNDS | 0.01% | 68906 SH | 2026年8月19日 | 每日 |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.01% | 2303 SH | 2026年10月2日 | 每日 |
| ACWI · iShares Trust | 0.00% | 8307 SH | 2026年9月11日 | 每日 |
| IJH · iShares Trust | · | 1828162 SH | 2026年9月11日 | 每日 |
| IJJ · iShares Trust | · | 265658 SH | 2026年8月21日 | 每日 |
| ISCB · iShares Trust | · | 2352 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 6481 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 4872 SH | 2026年9月1日 | 每日 |
MOH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
17 位分析师 · 2026-09-30平均目标 $209.12 +10.3%
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。